Followers | 3183 |
Posts | 208744 |
Boards Moderated | 2 |
Alias Born | 02/04/2004 |
Wednesday, February 06, 2019 8:56:08 AM
They decided to reach out to a 3rd firm at the end of last week, just because they were told that getting a share repurchase program through all the compliance of both a brokerage firm and clearing firm, is surprisingly 1 of the hardest endeavors to undertake right now, because apparently so many big board firms have been doing share repurchase programs over the past year with some of their corporate profits so there's lots of vetting required to get through compliance for any PubCo's wanting to do 1 these days.
With that said however, he whole-heartedly believes that they've already cleared the brokerage firm compliance department hurdle and are now waiting on the clearing firm compliance department to give the thumbs up so to speak which could literally happen any day now!
He also told me that they remain completely on track on the Rotmans Super 8k acquisition filing front, and even re-hired the old operations manager at Rotmans to assist the auditors working on the Rotmans audited financials which must be included with the Rotmans Super 8k! Apparently the woman is a whiz and knows Rotmans inside out...so to ensure a smooth overall transition of integrating Rotmans into VYST she has agreed to come back on for a 6 month contract spell to aid in all the moving parts of the integration. He also did say that Friday February 15th isn't a due date for the pending Rotmans Super 8k...it's just an approx. timeframe they're shooting for give or take 2 or 3 days one way or the other, and that they're clearly trying to get it filed as soon as humanly possible the moment the audited fins are signed off on by the auditing firm ok!
He also told me that they have lots of exciting material developments occurring behind the scenes right now and that they will soon begin updating the market on what that all means!
I asked him straight up if they would be uplisting to the QB and QX exchanges ahead of their Nasdaq uplisting pursuit and he straight up told me that I would have to pay attention to the upcoming news wires as some questions he simply cannot answer right now in order to stay within the confines of fair disclosure!
He then spent some time going over a couple of VYST's insiders who have significant pedigree, 1 of which is on their BOD's and who is considered the pre-eminent latex scientist in the world today! He ended the call by talking about all the cutting and competitive edge advantages VYST's proprietary latex possesses over everything else out there in the global market today! It was really eye opening to hear him explain the process of how they remove the ammonia right on the plantation within 6 hours prior to it even being sent to the processing plants! And how VYST's latex can stay in the processing plants lines for 5 days without the lines even being in operation...whereas most latex out there needs to be removed from the lines every morning that the processing lines get turned back on...which can save the processing plant operations $10's of thousands of dollars worth of lost latex every month alone! Also by removing the ammonia right on the plantation VYST's products contain none of the tiny bubbles prevalent in so many other latex products that don't remove the ammonia on site!
All in all it was another great call and I find Greg to be extremely knowledgeable and as excited about the immediate future of VYST's direction as the majority of us new shareholders are glta!
Recent VYST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 08:06:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 11:01:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 07:36:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:46:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:41:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/10/2023 09:14:55 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM